Home LiteratureArticle Details
PMID: 8666151 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.

Diabetes ·Vol. 45 ·No. 7 ·1996-07-00 ·Pages 974-9

Groop PH, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen MR

Abstract

The aim of this study was to characterize abnormalities of triglyceride-rich apolipoprotein (apo) B-containing lipoproteins in type I diabetic patients with elevated albumin excretion rates (AERs). Sixty-four patients (31 men, 33 women) with normoalbuminuria (AER <20 microg/min), 52 (35 men, 17 women) with microalbuminuria (AER 20-200 microg/min), and 37 (17 men, 20 women) with albuminuria (AER >200 microg/min) and 56 healthy control subjects matched for age and body weight were studied. The major finding was increased mass concentrations of the highly atherogenic intermediate-density lipoprotein fraction in patients with microalbuminuria (P < 0.05) and albuminuria (P < 0.05), compared with those with normoalbuminuria. Triglyceride, free cholesterol, cholesterol ester, and phospholipid concentrations in the VLDL, intermediate-density lipoprotein, and LDL (P < 0.05-0.01), as well as total cholesterol, total triglyceride, and apoB concentrations were higher in patients with renal disease than in those without. Notably, there were no differences between patients with microalbuminuria and albuminuria. Only minor compositional changes could be detected. Postheparin plasma lipoprotein lipase (LPL) activities were identical, but hepatic lipase activities were higher in microalbuminuric and albuminuric patients than in normoalbuminuric patients (P < 0.01). LPL activity and VLDL1, (Sf 60-400) (r = -0.528; P < 0.001) and VLDL2 (Sf 20-60) mass concentrations (r = -0.471; P < 0.001) were negatively related. In conclusion, in type I diabetic patients with early renal disease, there are multiple lipoprotein changes, which are potentially atherogenic and may contribute to the excess of macrovascular complications seen in such patients.

MeSH Terms
Adult Albuminuria Analysis of Variance Apolipoproteins B/blood Blood Pressure Cholesterol/blood Cholesterol Esters/blood Diabetes Mellitus, Type 1/blood,physiopathology,urine Diabetic Nephropathies/blood,physiopathology,urine Female Glycated Hemoglobin A/analysis Heparin Humans Lipoprotein Lipase/blood Lipoproteins/blood,isolation & purification Lipoproteins, IDL Lipoproteins, LDL/blood Lipoproteins, VLDL/blood Male Middle Aged Phospholipids/blood Reference Values Triglycerides/blood
Chemicals
Apolipoproteins B Cholesterol Esters Glycated Hemoglobin A Lipoproteins Lipoproteins, IDL Lipoproteins, LDL Lipoproteins, VLDL Phospholipids Triglycerides Heparin Cholesterol Lipoprotein Lipase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Groop P H
Unit for Metabolic Medicine, Guy's Hospital, London, UK.
Elliott T
Ekstrand A
Franssila-Kallunki A
Friedman R
Viberti G C
Taskinen M R
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
1996-07-00
Pages
974-9
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com